Table T-KVa.1
KV Pharmceutical Company
Balance Sheets (in $ millions)
.	1999	1998	1997
Assets	.	.	.
Cash	10140	18158	7628
Receivables	18988	15304	8580
Inventory	23653	15606	12786
Other current assets	16800	3491	1230
Total Current Assets	69581	52559	30224
Fixed Assets	18967	12437	8118
Intangibles	.	.	.
Other	39442	3365	3021
Total Assets	127990	68361	41363
Liabilities	.	.	.
Notes payable	.	.	.
Current portion of LTD	712	558	351
Trade Payable	8667	4281	2045
Tax Payable	.	.	.
Other Current Liabilites	17090	12317	2810
Total Current Liabilities	26469	17156	5206
Long Term Debt (LTD)	31491	4902	2158
Postretirement benefits	.	.	.
Deferred Taxes	379	535	.
Other	2103	1603	913
Equity	67548	44164	33084
Total	127990	68360	41361
Source: KV Pharmaceutical Company Annual Reports

Table T-KVa.2
KV Pharmceutical Company
Income Statements (in $ millions)
.	2000	1999	1998	1997	1996
Sales	145,970	114,860	98,486	57,890	49,729
Cost of Goods Sold	63,446	61,415	56,483	29,478	26,260
Gross Profit	82,524	53,445	42,003	28,412	23,469
Operating Expenses	48,332	29,329	25,110	18,841	18,019
Operating Profit	34,192	24,116	16,893	9,571	5,450
Interest	1,932	498	452	411	1,377
Other	-6,839	-14,014	-550	-146	-59
Profit before tax	39,099	37,632	16,991	9,306	4,132
Tax	14,791	14,292	5,687	383	90
Profit after tax	24,308	23,340	11,304	8,923	4,042
EPS	1	1	1	0	0
Dividends	0	0	0	0	0
Stock price	22	25	20	11	8
Source: KV Pharmaceutical Company Annual Reports

Table T-KVa.3
KV Pharmceutical Company
Normalized Balance Sheets
.	1999	1998	1997
Assets	.	.	.
Cash	8	27	18
Receivables	15	22	21
Inventory	18	23	31
Other current assets	13	5	3
Total Current Assets	54	77	73
Fixed Assets	15	18	20
Intangibles	0	0	0
Other	31	5	7
Total Assets	100	100	100
Liabilities	.	.	.
Notes payable	0	0	0
Current portion of LTD	1	1	1
Trade Payable	7	6	5
Tax Payable	0	0	0
Other Current Liabilites	13	18	7
Total Current Liabilities	21	25	13
Long Term Debt (LTD)	25	7	5
Postretirement benefits	0	0	0
Deferred Taxes	0	1	0
Other	2	2	2
Equity	53	65	80
Total	100	100	100
Source: KV Pharmaceutical Company Annual Reports

Table T-KVa.4
KV Pharmceutical Company
Normalized Income Statements
.	1999	1998	1997	1996
Sales	100	100	100	100
Cost of Goods Sold	53	57	51	53
Gross Profit	47	43	49	47
Operating Expenses	26	25	33	36
Operating Profit	21	17	17	11
Interest	0	0	1	3
Other	0	0	1	3
Profit before tax	33	17	16	8
Tax	12	6	1	0
Profit after tax	20	11	15	8
Source: KV Pharmaceutical Company Annual Reports

Table T-KVa.5
KV Pharmceutical Company
Ratios
	1999	1998	1997
Current ratio	2.63	3.06	5.81
Quick ratio	1.1	1.95	3.11
Working capital (in $ millions)	43112	35403	25018
Receivables turnover	6.05	6.44	6.75
DSO (in days)	60	57	54
Inventory turnover	2.6	3.62	2.31
DSI (in days)	140	101	158
Payables turnover	7.09	13.19	14.41
DPO (in days)	51	28	25
Working capital turnover	2.66	2.78	2.31
TIE	48.43	37.37	23.29
Fixed assets/equity	0.28	0.28	0.25
Debt/equity	0.86	0.5	0.22
Pbt/equity	0.56	0.38	0.28
Pbt/total assets	0.29	0.25	0.22
Pat/equity	0.35	0.26	0.27
Pat/total assets	0.18	0.17	0.22
Sales/fixed assets	6.06	7.92	7.13
Sales/total assets	0.9	1.44	1.4
Payout	0	0	0
P/E	21	34	23

ÿÿÿ